Research article · 2016
Conference abstractPublished 24 Oct 2013
New scientific findings regarding a higher risk of cardiovascular events under highly active antiretroviral therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
S ustained HIV suppression depends on a combination of factors influencing each other. One of the most important factors is the management of numerous acute or chronic side effects, such as hematological abnormalities, dyslipidemia, polyneuropathy, mitochondrial toxicities, insulin resistance, organic toxicities and lipodystrophy. A current challenge is the prevention of cardiovascular events (CVE) evolving during therapy. Especially, HIV protease inhibitors are correlated with a higher risk of myocardial infarction and other cardiovascular events, even in middle-aged patients. The cause seems to be multifactorial, but is also partly unknown: Dyslipidemia plus early atherosclerosis are responsible for changes in the circulation system, leading to more and earlier CVE. However, also inflammatory processes in the vessels, which are maintained by the activation of thrombocytes seem to play a role. HIV-PLA I and II are two studies evaluating thrombocyte activation and thrombocyte/leucocyte adhesion under HAART in ex-vivo in-vitro . The HIV-PLA II study finishes in 2013. The final results of these two studies will be presented and factors discussed leading to the higher risk for CVE under HAART and its implications for future HIV drug development.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2013
The Impact of a Health Promotion Educational Program on Cardiovascular Risk Factors for HIV Infected Women on Antiretroviral Therapy
Short communication · 28 Nov 2024
Treating People Living with HIV Using Highly Active Antiretroviral Therapy
Commentary · 5 Jul 2024
The Innovative Role of Highly Active Antiretroviral Therapy in HIV Treatment
Short communication · 5 Jan 2024
Highly Active Antiretroviral Therapy: A Comprehensive Approach to HIV Treatment
More from this journal
The newest in Journal of AIDS & Clinical Research.
Article · 25 Feb 2026
The Effect of Quality of Service on Customer Satisfaction in Ethiopian Pharmaceutical Supply Agency (EPSA): Case Study Bahir Dar Branch
Article · 22 Feb 2026
Drug Resistance and Quality of Life and their Associated Factors for HIV Patients under Treatment at the Second Line Regimens in Public Hospitals in Amhara Region, North-West Ethiopia
Article · 22 Feb 2026
Assessment of Public Knowledge, Attitude and Practices (KAP) and its Predictors towards Rabies Disease among Rural Households in North Wollo Zone, Ethiopia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of AIDS & Clinical Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Nils von Hentig”

